Avonex for Multiple Sclerosis
Links shared publicly online about this topic
Biogen Idec Reports Positive Data From AVONEX Dose Titration Study At 2011 Annual Meeting Of The Consortium Of Multiple Sclerosis Centers
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) today announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of AVONEX®(interferon beta-1a) dose titration, or” View full resource at medicalnewstoday.com
Most Recently Shared on June 6, 2011 at 3:05 pm By:
Biogen Idec Reports Positive Data From AVONEX Dose Titration Study At 2011 Annual Meeting Of The Consortium Of Multipl... http://mnt.to/3WNZ
Fewer Injection Site Reactions In Patients Using AVONEX Versus Sub-cutaneous Interferon And Glatiramer Acetate For The Treatment Of Multiple Sclerosis
medicalnewstoday.com — “Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantl” View full resource at medicalnewstoday.com
Most Recently Shared on September 13, 2009 at 11:50 am By:
MedNewsToday: Fewer Injection Site Reactions In Patients Using AVONEX Versus Sub-cutaneous Interfer.. http://bit.ly/cBg1N
First 10-YTear Follow-Up Shows That Treatment With AVONEX Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) has announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surve” View full resource at medicalnewstoday.com
Most Recently Shared on May 2, 2009 at 11:07 am By:
MedNewsToday: First 10-YTear Follow-Up Shows That Treatment With AVONEX Leads To Long-Term Benefits.. http://tinyurl.com/cfwmlh
First Ten-Year Follow-Up Shows That Treatment With AVONEX Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) announced data results from the CHAMPIONS ( C ontrolled H igh-Risk A VONEX ® (interferon beta-1a) M ultiple Sclerosis (MS) P revention Study I n O ngoing N eurologi” View full resource at medicalnewstoday.com
Most Recently Shared on May 4, 2009 at 3:03 pm By:
MedNewsToday: First Ten-Year Follow-Up Shows That Treatment With AVONEX Leads To Long-Term Benefits.. http://tinyurl.com/cpbwxv
Avonex IM Uses and How to Use
healthcentral.com — “Avonex side effects, dosage, and drug interactions. All accurate, up-to-date information is written for the consumer by healthcare professionals.” View full resource at healthcentral.com
Most Recently Shared on September 2, 2011 at 8:29 pm By:
@PetraW1976 Sure do. We've got the basic usage & used for information for it here: http://t.co/FbgaP5T #MultipleSclerosis
Biogen Idec Reports Positive Data from AVONEX Dose Titration Study at 2011 Annual Meeting of the Consortium of Multiple Sclerosis Centers - Drugs.com MedNews
drugs.com — “-Data Show that Titrating AVONEX at Initiation of Treatment Reduced Severity of Flu-like Symptoms- Jun 6, 2011 - Biogen Idec (NASDAQ BIIB) today announced the f” View full resource at drugs.com
Most Recently Shared on June 6, 2011 at 2:07 pm By:
Biogen Idec Reports Positive Data from AVONEX Dose Titration Study at 2011 Annual Meeting of the Consortiu... http://bit.ly/mJMKtF #drug
First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveilla” View full resource at medicalnewstoday.com
Most Recently Shared on July 4, 2009 at 11:05 am By:
MedNewsToday: First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefit.. http://tinyurl.com/nguutu
First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) today announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Sur” View full resource at medicalnewstoday.com
Most Recently Shared on September 8, 2009 at 11:52 am By:
MedNewsToday: First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefit.. http://bit.ly/1qsCyy
Brass and Ivory: Too tired to blog. Read about Biogen and Avonex instead.
brassandivory.blogspot.com — “Support and advice for living and coping with multiple sclerosis and rheumatoid arthritis. Read about one woman\” View full resource at brassandivory.blogspot.com
Most Recently Shared on September 16, 2009 at 7:21 pm By:
Too tired to blog. Read about Biogen and Avonex instead.: I am so utterly exhausted and fatigued that I can hard.. http://bit.ly/1Z254u
Multiple Sclerosis - Mediitation for Multiple Sclerosis
healthcentral.com — “Meditation and yoga can be beneficial to those of us with MS. Meditation is a contemplative mental exercise for complete relaxation or awareness.” View full resource at healthcentral.com
Most Recently Shared on May 19, 2010 at 7:03 pm By:
Yoga and Meditation for Multiple Sclerosis ... http://dld.bz/ege8
Multiple Sclerosis - Parenting with Multiple Sclerosis
healthcentral.com — “It isn't supposed to be this way is it? You are the parent and have children to take care of. Yet now you are faced with this disease and you wonder if in time your kids will be taking care of you.” View full resource at healthcentral.com
Most Recently Shared on December 9, 2009 at 3:31 pm By:
Is MS Hereditary? - Multiple Sclerosis
healthcentral.com — “Like many people when first diagnosed with MS, I asked the question, --Will my children get MS?-- I was told no. That was 20 years ago. Is that still the case?” View full resource at healthcentral.com
Most Recently Shared on March 21, 2011 at 4:45 pm By:
Research indicates men with MS are 2x as likely as women with MS to pass it on to their children. http://bit.ly/f9tUbv Is MS hereditary?
Multiple Sclerosis - The Week in Review, June 19, 2009
healthcentral.com — “Welcome to the Week in Review which provides us an opportunity to catch up with our community during the past seven days. If you do not already, please look around and get to know some of the other members on site, especially from the comment sections. ” View full resource at healthcentral.com
Most Recently Shared on June 19, 2009 at 8:21 pm By:
The Week in Review, June 19, 2009: Welcome to the Week in Review which provides us an opportunity to catch up wi.. http://tinyurl.com/mxz6sw
Gilenya (fingolimod), first MS oral drug, will be available in US with financial help from Novartis - Multiple Sclerosis
healthcentral.com — “Even before I was diagnosed with MS in 2005, I researched the different treatment options. I learned about the ABC’s (Avonex, Betaseron, Copaxone),...” View full resource at healthcentral.com
Most Recently Shared on October 5, 2010 at 8:30 pm By:
Gilenya (fingolimod), first MS oral drug, will be available in US with financial help from Novartis http://ow.ly/19iRvv
Multiple Sclerosis
nlm.nih.gov — “Multiple Sclerosis” View full resource at nlm.nih.gov
Most Recently Shared on August 27, 2009 at 11:58 pm By:
@sweetyliza32 Liza, Multiple Sclerosis or MS is a medical condition: http://j.mp/cuXjlm
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Multiple Scl
The latest multiple sclerosis news published daily. Articles from research centers, universities and prestigious journals.
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
Advertisement

